Skip to main content
SpringerLink
Log in

Molecular Pathology of Histiocytic Disorders

  • Chapter
  • First Online:
Molecular Pathology of Hematolymphoid Diseases

Part of the book series: Molecular Pathology Library ((MPLB,volume 4))

  • 1295 Accesses

Abstract

Histiocytic disorders are diseases characterized by the proliferation and/or accumulation of histocytic cells in bone marrow (BM), peripheral blood (PB), and a variety of extramedullary tissues, associated with variable local and systemic symptoms, which depend on the disease subtype. Histiocytes are hematopoietic cells that derive from BM progenitors and have important functions in the immune system, including antigen presentation and antigen processing. Normal histiocytes include multiple functional subsets with distinct morphology, immunophenotype, and tissue localization. Histiocytic dis-orders are currently classified according to their morphologic and immunophenotypic resemblance to these normal counterparts, as well as according to their clinical presentation and biologic behavior (Table 42.1). The immunohistochemical classification of the tumors of histiocytes and accessory dendritic cells proposed by the International Lymphoma Study Group comprises two major categories: disorders of varied biologic behavior and malignant disorders. This chapter will focus on the former category, which includes clonal and non-clonal entities, none of which may be definitively classified as malignant, although their clinical behavior may be aggressive and even fatal (Table 42.2). The malignant disorders include sarcomas with histiocytic or dendritic cell differentiation, as well as acute myeloid leukemias (AMLs) with monocytic or monoblastic differentiation. Due to the rarity and thus lack of a significant amount of molecular data, sarcomas with histiocytic or dendritic cell differentiation will not be addressed in this chapter. For a discussion of AMLs with monocytic or monoblastic differentiation, see Chaps. 34 and 35.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Favara BE, Feller AC, Pauli M, et al. Contemporary classification of histiocytic disorders. The WHO committee on histiocytic/reticulum cell proliferations. Reclassification working group of the histiocyte society. Med Pediatr Oncol. 1997;29:157–166.

    Article  PubMed  CAS  Google Scholar 

  2. Pileri SA, Grogan TM, Harris NL, et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 2002;41:1–29.

    Article  PubMed  CAS  Google Scholar 

  3. Beverley PC, Egeler RM, Arceci RJ, Pritchard J. The Nikolas symposia and histiocytosis. Nat Rev Cancer. 2005;5(6):488–494.

    Article  PubMed  CAS  Google Scholar 

  4. Egeler RM, Neglia JP, Puccetti DM, Brennan CA, Nesbit ME. Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer. 1993;71:865–873.

    Article  PubMed  CAS  Google Scholar 

  5. Magni M, Di Nicola M, Carlo-Stella C, et al. Identical rearrangement of immunoglobulin heavy chain gene in neoplastic Langerhans cells and B-lymphocytes: evidence for a common precursor. Leuk Res. 2002;26(12):1131–1133.

    Article  PubMed  CAS  Google Scholar 

  6. Weitzman S, Egeler RM. Langerhans cell histiocytosis: update for the pediatrician. Curr Opin Pediatr. 2008;20:23–29.

    Article  PubMed  Google Scholar 

  7. Yousem SA, Colby TV, Chen YY, Chen WG, Weiss LM. Pulmonary Langerhans cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol. 2001;25(5):630–636.

    Article  PubMed  CAS  Google Scholar 

  8. Bechan GI, Egeler RM, Arceci RJ. Biology of Langerhans cells and Langerhans cell histiocytosis. Int Rev Cytol. 2006;254:1–43.

    Article  PubMed  CAS  Google Scholar 

  9. Nezelof C, Basset F. An hypothesis Langerhans cell histiocytosis: the failure of the immune system to switch from an innate to an adaptive mode. Pediatr Blood Cancer. 2004;42:398–400.

    Article  PubMed  Google Scholar 

  10. Annels NE, Da Costa CE, Prins FA, Willemze A, Hogendoorn PCW, Egeler RM. Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis. J Exp Med. 2003;197:1385–1390.

    Article  PubMed  CAS  Google Scholar 

  11. Egeler RM, Annels NE, Hogendoorn PC. Langerhans cell histiocytosis: a pathologic combination of oncogenesis and immune dysregulation. Pediatr Blood Cancer. 2004;42(5):401–403.

    Article  PubMed  Google Scholar 

  12. Geissmann F, Lepelletier Y, Fraitag S, et al. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood. 2001;97(5):1241–1248.

    Article  PubMed  CAS  Google Scholar 

  13. Ratzinger G, Burgdorf WH, Metze D, Zelger BG, Zelger B. Indeterminate cell histiocytosis: fact or fiction? J Cutan Pathol. 2005;32(8):552–560.

    Article  PubMed  Google Scholar 

  14. Rodriguez-Jurado R, Vidaurri-De La Cruz H, Duran-Mckinster C, Ruiz-Maldonado R. Indeterminate cell histiocytosis. Clinical and pathologic study in a pediatric patient. Arch Pathol Lab Med. 2003;127:748–751.

    PubMed  Google Scholar 

  15. Arico M, Danesino C. Langerhans’ cell histiocytosis: is there a role for genetics? Haematologica. 2001;86:1009–1014.

    PubMed  CAS  Google Scholar 

  16. Sheils C, Dover GJ. Frequency of congenital anomalies in patients with histiocytosis X. Am J Hematol. 1989;31(2):91–95.

    Article  PubMed  CAS  Google Scholar 

  17. Egeler RM, Neglia JP, Arico M, Favara BE, Heitger A, Nesbit ME. Acute leukemia in association with Langerhans cell histiocytosis. Med Pediatr Oncol. 1994;23:81–85.

    Article  PubMed  CAS  Google Scholar 

  18. Scappaticci S, Danesino C, Rossi E, et al. Cytogenetic abnormalities in PHA-stimulated lymphocytes from patients with Langerhans cell histocytosis. AIEOP-Istiocitosi Group. Br J Haematol. 2000;111(1):258–262.

    Article  PubMed  CAS  Google Scholar 

  19. Di Rocco M, Arslanian A, Romanengo M, Dagna-Bricarelli F, Borrone C. Ataxia, ocular telangiectasia, chromosome instability, and Langerhans cell histiocytosis in a patient with an unknown breakage syndrome. J Med Genet. 1999;36(2):159–160.

    PubMed  Google Scholar 

  20. De Filippi P, Badulli C, Cuccia M, et al. Specific polymorphisms of cytokine genes are associated with different risks to develop single-system or multi-system childhood Langerhans cell histiocytosis. Br J Haematol. 2006;132(6):784–787.

    Article  PubMed  CAS  Google Scholar 

  21. Mcclain KL, Laud P, Wu WS, Pollack MS. Langerhans cell histiocytosis patients have HLA Cw7 and DR4 types associated with specific clinical presentations and no increased frequency in polymorphisms of the tumor necrosis factor alpha promoter. Med Pediatr Oncol. 2003;41(6):502–507.

    Article  PubMed  Google Scholar 

  22. Boxall S, Mccormick J, Beverley P, et al. Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis. Pediatr Res. 2004;55(3):478–484.

    Article  PubMed  CAS  Google Scholar 

  23. Willman CL, Mcclain KL. An update on clonality, cytokines, and viral etiology in Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1998;12(2):407–416.

    Article  PubMed  CAS  Google Scholar 

  24. Betts DR, Leibundgut KE, Feldges A, Plüss HJ, Niggli FK. Cytogenetic abnormalities in Langerhans cell histiocytosis. Br J Cancer. 1998;77(4):552–555.

    Article  PubMed  CAS  Google Scholar 

  25. Ornvold K, Carstensen H, Larsen JK, Christensen J, Ralfkiaer E. Flow cytometric DNA analysis of lesions from 18 children with Langerhans cell histiocytosis (histiocytosis X). Am J Pathol. 1990;136:1301–1307.

    PubMed  CAS  Google Scholar 

  26. Willman CL. Detection of clonal histiocytes in Langerhans cell histiocytosis: biology and clinical significance. Br J Cancer Suppl. 1994;23:S29–S33.

    PubMed  CAS  Google Scholar 

  27. Willman CL, Busque L, Griffith BB, et al. Langerhans’-cell histiocytosis (histiocytosis X) – a clonal proliferative disease. N Engl J Med. 1994;331:154–160.

    Article  PubMed  CAS  Google Scholar 

  28. Yu RC, Chu AC, Chu C, Buluwela L. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet. 1994;343:767–768.

    Article  PubMed  CAS  Google Scholar 

  29. Murakami I, Gogusev J, Fournet JC, Glorion C, Jaubert F. Detection of molecular cytogenetic aberrations in Langerhans cell histiocytosis of bone. Hum Pathol. 2002;33(5):555–560.

    Article  PubMed  CAS  Google Scholar 

  30. Rust R, Kluiver J, Visser L, et al. Gene expression analysis of dendritic/Langerhans cells and Langerhans cell histiocytosis. J Pathol. 2006;209(4):474–483.

    Article  PubMed  CAS  Google Scholar 

  31. Schouten B, Egeler RM, Leenen PJ, Taminiau AH, Van den Broek LJ, Hogendoorn PC. Expression of cell cycle-related gene products in Langerhans cell histiocytosis. J Pediatr Hematol Oncol. 2002;24(9):727–732.

    Article  PubMed  Google Scholar 

  32. Bank MI, Rengtved P, Carstensen H, Petersen BL. p53 expression in biopsies from children with Langerhans cell histiocytosis. J Pediatr Hematol Oncol. 2002;24(9):733–736.

    Article  PubMed  Google Scholar 

  33. Savell VH Jr, Sherman T, Scheuermann RH, Siddiqui AM, Margraf LR. Bcl-2 expression in Langerhans’ cell histiocytosis. Pediatr Dev Pathol. 1998;1(3):210–215.

    Article  PubMed  Google Scholar 

  34. Weintraub M, Bhatia KG, Chandra RS, Magrath IT, Ladisch S. p53 expression in Langerhans cell histiocytosis. J Pediatr Hematol Oncol. 1998;20(1):12–17.

    Article  PubMed  CAS  Google Scholar 

  35. Murray D, Marshall M, England E, Mander J, Chakera TM. Erdheim-Chester disease. Clin Radiol. 2001;56:481–484.

    Article  PubMed  CAS  Google Scholar 

  36. Shamburek RD, Brewer HB Jr, Gochuico BR. Erdheim-Chester disease: a rare multisystem histiocytic disorder associated with interstitial lung disease. Am J Med Sci. 2001;321(1):66–75.

    Article  PubMed  CAS  Google Scholar 

  37. Breuil V, Brocq O, Pellegrino C, Grimaud A, Euller-Ziegler L. Erdheim-Chester disease: typical radiological bone features for a rare xanthogranulomatosis. Ann Rheum Dis. 2002;61:199–200.

    Article  PubMed  CAS  Google Scholar 

  38. Al Quran S, Reith J, Bradley J, Rimsza L. Erdheim-Chester disease: case report, PCR-based analysis of clonality, and review of literature. Mod Pathol. 2002;15(6):666–672.

    Article  PubMed  Google Scholar 

  39. Sivak-Callcott JA, Rootman J, Rasmussen SL, et al. Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review. Br J Ophthalmol. 2006;90:602–608.

    Article  PubMed  CAS  Google Scholar 

  40. Vencio EF, Jenkins RB, Schiller JL, et al. Clonal cytogenetic abnormalities in Erdheim-Chester disease. Am J Surg Pathol. 2007;31(2):319–321.

    Article  PubMed  Google Scholar 

  41. Boralevi F, Leaute-Labreze C, Tison F, et al. Langerhans-cell histiocytosis and Erdheim-Chester disease: probably not a fortuitous association. Ann Dermatol Venereol. 1998;125(5):335–338.

    PubMed  CAS  Google Scholar 

  42. Vital C, Bioulac-Sage P, Tison F, et al. Brain stem infiltration by mixed Langerhans cell histiocytosis and Chester-Erdheim disease: more than just an isolated case? Clin Exp Pathol. 1999;47(2):71–76.

    PubMed  CAS  Google Scholar 

  43. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, et al. Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore). 1996;75(3):157–169.

    Article  CAS  Google Scholar 

  44. Stoppacciaro A, Ferrarini M, Salmaggi C, et al. Immunohisto-chemical evidence of a cytokine and chemokine network in three patients with Erdheim-Chester disease: implications for pathogenesis. Arthritis Rheum. 2006;54(12):4018–4022.

    Article  PubMed  CAS  Google Scholar 

  45. Mossetti G, Rendina D, Numis FG, Somma P, Postiglione L, Nunziata V. Biochemical markers of bone turnover, serum levels of interleukin-6/interleukin-6 soluble receptor and bisphosphonate treatment in Erdheim-Chester disease. Clin Exp Rheumatol. 2003;21(2):232–236.

    PubMed  CAS  Google Scholar 

  46. Chetritt J, Paradis V, Dargere D, et al. Chester-Erdheim ­disease: a neoplastic disorder. Hum Pathol. 1999;30(9):1093–1096.

    Article  PubMed  CAS  Google Scholar 

  47. Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–131.

    Article  PubMed  Google Scholar 

  48. Emminger W, Zlabinger GJ, Fritsch G, Urbanek R. CD14(dim)/CD16(bright) monocytes in hemophagocytic lymphohistiocytosis. Eur J Immunol. 2001;31(6):1716–1719.

    Article  PubMed  CAS  Google Scholar 

  49. Karandikar NJ, Kroft SH, Yegappan S, et al. Unusual immunophenotype of CD8+ T cells in familial hemophagocytic lymphohistiocytosis. Blood. 2004;104(7):2007–2009.

    Article  PubMed  CAS  Google Scholar 

  50. Lin MT, Chang HM, Huang CJ, et al. Massive expansion of EBV+ monoclonal T cells with CD5 down regulation in EBV-associated haemophagocytic lymphohistiocytosis. J Clin Pathol. 2007;60(1):101–103.

    Article  PubMed  CAS  Google Scholar 

  51. Mccormick J, Flower DR, Strobel S, Wallace DL, Beverley PC, Tchilian EZ. Novel perforin mutation in a patient with hemophagocytic lymphohistiocytosis and CD45 abnormal splicing. Am J Med Genet. 2003;117a(3):255–260.

    Article  PubMed  Google Scholar 

  52. Clementi R, Zur SU, Savoldi G, et al. Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis. J Med Genet. 2001;38(9):643–646.

    Article  PubMed  CAS  Google Scholar 

  53. Ericson KG, Fadeel B, Andersson M, et al. Sequence analysis of the granulysin and granzyme B genes in familial hemophagocytic lymphohistiocytosis. Hum Genet. 2003;112:98–99.

    Article  PubMed  CAS  Google Scholar 

  54. Kogawa K, Lee SM, Villanueva J, Marmer D, Sumegi J, Filipovich AH. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood. 2002;99:61–66.

    Article  PubMed  CAS  Google Scholar 

  55. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286(5446):1957–1959.

    Article  PubMed  CAS  Google Scholar 

  56. Matloubian M, Suresh M, Glass A, et al. A role for perforin in downregulating T-cell responses during chronic viral infection. J Virol. 1999;73(3):2527–2536.

    PubMed  CAS  Google Scholar 

  57. Feldmann J, Callebaut I, Raposo G, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003;115(4):461–473.

    Article  PubMed  CAS  Google Scholar 

  58. Marcenaro S, Gallo F, Martini S, et al. Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood. 2006;108(7):2316–2323.

    Article  PubMed  CAS  Google Scholar 

  59. Zur SU, Schmidt S, Kasper B, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet. 2005;14(6):827–834.

    Article  Google Scholar 

  60. Bryceson YT, Rudd E, Zheng C, et al. Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood. 2007;110(6):1906–1915.

    Article  PubMed  CAS  Google Scholar 

  61. Wagner R, Morgan G, Strobel S. A prospective study of CD45 isoform expression in haemophagocytic lymphohistiocytosis: an abnormal inherited immunophenotype in one family. Clin Exp Immunol. 1995;99(2):216–220.

    Article  PubMed  CAS  Google Scholar 

  62. Chang YH, Lee DS, Jo HS, et al. Tumor necrosis factor alpha promoter polymorphism associated with increased susceptibility to secondary hemophagocytic lymphohistiocytosis in the Korean population. Cytokine. 2006;36(1-2):45–50.

    Article  PubMed  CAS  Google Scholar 

  63. Osugi Y, Hara J, Tagawa S, et al. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood. 1997;89:4100–4103.

    PubMed  CAS  Google Scholar 

  64. Takada H, Nomura A, Ohga S, Hara T. Interleukin-18 in hemophagocytic lymphohistiocytosis. Leuk Lymphoma. 2001;42(1–2):21–28.

    Article  PubMed  CAS  Google Scholar 

  65. Dehner LP. Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am J Surg Pathol. 2003;27(5):579–593.

    Article  PubMed  Google Scholar 

  66. Stover DG, Alapati S, Regueira O, Turner C, Whitlock JA. Treatment of juvenile xanthogranuloma. Pediatr Blood Cancer. 2008;51(1):130–133.

    Article  PubMed  Google Scholar 

  67. De Graaf JH, Timens W, Tamminga RY, Molenaar WM. Deep juvenile xanthogranuloma: a lesion related to dermal indeterminate cells. Hum Pathol. 1992;23(8):905–910.

    Article  PubMed  Google Scholar 

  68. Kraus MD, Haley JC, Ruiz R, Essary L, Moran CA, Fletcher CD. “Juvenile” xanthogranuloma: an immunophenotypic study with a reappraisal of histogenesis. Am J Dermatopathol. 2001;23(2):104–111.

    Article  PubMed  CAS  Google Scholar 

  69. Mancini AJ, Prieto VG, Smoller BR. Role of cellular proliferation and apoptosis in the growth of xanthogranulomas. Am J Dermatopathol. 1998;20(1):17–21.

    Article  PubMed  CAS  Google Scholar 

  70. Radio SJ, Wooldridge TN, Linder J. Flow cytometric DNA analysis of malignant fibrous histiocytoma and related fibrohistiocytic tumors. Hum Pathol. 1988;19(1):74–77.

    Article  PubMed  CAS  Google Scholar 

  71. Janssen D, Folster-Holst R, Harms D, Klapper W. Clonality in juvenile xanthogranuloma. Am J Surg Pathol. 2007;31(5):812–813.

    Article  PubMed  Google Scholar 

  72. Onciu M, Medeiros LJ. Kikuchi-Fujimoto lymphadenitis. Adv Anat Pathol. 2003;10:204–211.

    Article  PubMed  Google Scholar 

  73. Feller AC, Lennert K, Stein H, Bruhn HD, Wuthe HH. Immunohistology and aetiology of histiocytic necrotizing lymphadenitis. Report of three instructive cases. Histopathology. 1983;7(6):825–839.

    Article  PubMed  CAS  Google Scholar 

  74. Pileri SA, Facchetti F, Ascani S, et al. Myeloperoxidase expression by histiocytes in Kikuchi’s and Kikuchi-like lymphadenopathy. Am J Pathol. 2001;159(3):915–924.

    PubMed  CAS  Google Scholar 

  75. Rivano MT, Falini B, Stein H, et al. Histiocytic necrotizing lymphadenitis without granulocytic infiltration (Kikuchi’s lymphadenitis). Morphological and immunohistochemical study of eight cases. Histopathology. 1987;11(10):1013–1027.

    Article  PubMed  CAS  Google Scholar 

  76. Tanaka T, Ohmori M, Yasunaga S, Ohshima K, Kikuchi M, Sasazuki T. DNA typing of HLA class II genes (HLA-DR, -DQ and -DP) in Japanese patients with histiocytic necrotizing lymphadenitis (Kikuchi’s disease). Tissue Antigens. 1999;54(3):246–253.

    Article  PubMed  CAS  Google Scholar 

  77. Amir AR, Amr SS, Sheikh SS. Kikuchi-Fujimoto’s disease: report of familial occurrence in two human leucocyte antigen-identical non-twin sisters. J Intern Med. 2002;252(1):79–83.

    Article  PubMed  CAS  Google Scholar 

  78. Hollingsworth HC, Peiper SC, Weiss LM, Raffeld M, Jaffe ES. An investigation of the viral pathogenesis of Kikuchi-Fujimoto disease. Lack of evidence for Epstein-Barr virus or human herpesvirus type 6 as the causative agents. Arch Pathol Lab Med. 1994;118(2):134–140.

    PubMed  CAS  Google Scholar 

  79. Krueger GR, Huetter ML, Rojo J, Romero M, Cruz-Ortiz H. Human herpesviruses HHV-4 (EBV) and HHV-6 in Hodgkin’s and Kikuchi’s diseases and their relation to proliferation and apoptosis. Anticancer Res. 2001;21(3C):2155–2161.

    PubMed  CAS  Google Scholar 

  80. Sumiyoshi Y, Kikuchi M, Ohshima K, et al. Human herpesvirus-6 genomes in histiocytic necrotizing lymphadenitis (Kikuchi’s disease) and other forms of lymphadenitis. Am J Clin Pathol. 1993;99(5):609–614.

    PubMed  CAS  Google Scholar 

  81. Stephan JL, Kone-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford). 2001;40:1285–1292.

    Article  CAS  Google Scholar 

  82. Chiu CF, Chow KC, Lin TY, Tsai MH, Shih CM, Chen LM. Virus infection in patients with histiocytic necrotizing lymphadenitis in Taiwan. Detection of Epstein-Barr virus, type I human T-cell lymphotropic virus, and parvovirus B19. Am J Clin Pathol. 2000;113:774–781.

    Article  PubMed  CAS  Google Scholar 

  83. Cho MS, Choi HJ, Park HK, Cho SE, Han WS, Yang WI. Questionable role of human herpesviruses in the pathogenesis of Kikuchi disease. Arch Pathol Lab Med. 2007;131(4):604–609.

    PubMed  CAS  Google Scholar 

  84. Rezvani I, Rosenblatt DS. Metabolic diseases. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson’s Texbook of Pediatrics. 16th ed. Philadelphia, PA: W.B. Saunders; 2000:343–450.

    Google Scholar 

  85. Wappner RS. Lysosomal storage disorders. In: Mcmillan JA, Feigin RD, Deangelis CD, Jones MD, eds. Oski’s Pediatrics. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:2199–2217.

    Google Scholar 

  86. Hrebicek M, Mrazova L, Seyrantepe V, et al. Mutations in TMEM76* cause mucopolysaccharidosis IIIC (Sanfilippo C syndrome). Am J Hum Genet. 2006;79(5):807–819.

    Article  PubMed  CAS  Google Scholar 

  87. Hruska KS, Lamarca ME, Scott CR, Sidransky E. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat. 2008;29(5):567–583.

    Article  PubMed  CAS  Google Scholar 

  88. Marcao AM, Wiest R, Schindler K, et al. Adult onset metachromatic leukodystrophy without electroclinical peripheral nervous system involvement: a new mutation in the ARSA gene. Arch Neurol. 2005;62(2):309–313.

    Article  PubMed  Google Scholar 

  89. Matsuda J, Yoneshige A, Suzuki K. The function of sphingolipids in the nervous system: lessons learnt from mouse models of specific sphingolipid activator protein deficiencies. J Neurochem. 2007;103(Suppl 1):32–38.

    Article  PubMed  CAS  Google Scholar 

  90. Michalski JC, Klein A. Glycoprotein lysosomal storage disorders: alpha- and beta-mannosidosis, fucosidosis and alpha-N-acetylgalactosaminidase deficiency. Biochim Biophys Acta. 1999;1455(2–3):69–84.

    PubMed  CAS  Google Scholar 

  91. Santamaria R, Chabas A, Callahan JW, Grinberg D, Villageliu L. Expression and characterization of 14 GLB1 mutant alleles found in GM1-gangliosidosis and Morquio B patients. J Lipid Res. 2007;48(10):2275–2282.

    Article  PubMed  CAS  Google Scholar 

  92. Schuchman EH. The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease. J Inherit Metab Dis. 2007;30(5):654–663.

    Article  PubMed  CAS  Google Scholar 

  93. Tomatsu S, Montano AM, Nishioka T, et al. Mutation and polymorphism spectrum of the GALNS gene in mucopoly-saccharidosis IVA (Morquio A). Hum Mutat. 2005;26(6):500–512.

    Article  PubMed  CAS  Google Scholar 

  94. Yogalingam G, Hopwood JJ. Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: diagnostic, clinical, and biological implications. Hum Mutat. 2001;18:264–281.

    Article  PubMed  CAS  Google Scholar 

  95. Yogalingam G, Guo XH, Muller VJ, et al. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy. Hum Mutat. 2004;24:199–207.

    Article  PubMed  CAS  Google Scholar 

  96. Clarke LA. The mucopolysaccharidoses: a success of molecular medicine. Expert Rev Mol Med. 2008;10:E1.

    Article  PubMed  Google Scholar 

  97. Grabowski GA. Treatment perspectives for the lysosomal storage diseases. Expert Opin Emerg Drugs. 2008;13(1):197–211.

    Article  PubMed  CAS  Google Scholar 

  98. Onciu M. Histiocytic proliferations in childhood. Am J Clin Pathol. 2004;122(suppl):S128–S136.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Anatomic pathology and Special Hematology Laboratories, Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN, USA

    Mihaela Onciu MD

Authors
  1. Mihaela Onciu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dept. Pathology & Laboratory Medicine, University of North Carolina, Chapel Hill, 27599-7525, USA

    Cherie H. Dunphy

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Onciu, M. (2010). Molecular Pathology of Histiocytic Disorders. In: Dunphy, C. (eds) Molecular Pathology of Hematolymphoid Diseases. Molecular Pathology Library, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-5698-9_42

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-5698-9_42

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-5697-2

  • Online ISBN: 978-1-4419-5698-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation